Cargando…

Novel application of drug-coated balloons in coronary heart disease: A narrative review

The incidence of coronary heart disease (CAD) has soared over the years, and coronary intervention has become an increasingly important therapeutic approach. The past decade has witnessed unprecedented developments in therapeutic medical instruments. Given that drug-coated balloons bring many benefi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lijin, Li, Xiaokang, Li, Tian, Liu, Lin, Wang, Haiyan, Wang, Chiyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017483/ https://www.ncbi.nlm.nih.gov/pubmed/36937937 http://dx.doi.org/10.3389/fcvm.2023.1055274

Ejemplares similares

Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction
por: Yang, Pei, et al.
Publicado: (2023)

Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
por: Lang, Xinyue, et al.
Publicado: (2022)

Short-term outcomes of drug-coated balloon versus drug-eluting stent for de novo saphenous vein graft lesions in coronary heart disease
por: Lin, Li, et al.
Publicado: (2023)

Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions
por: Yang, Xinyue, et al.
Publicado: (2022)

The factors influencing the efficiency of drug-coated balloons
por: Cao, Zheng, et al.
Publicado: (2022)

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
por: Hu, Feng-Wang, et al.
Publicado: (2022)

Effect of Drug-Coated Balloon in Side Branch Protection for de novo Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis
por: Zheng, Yawei, et al.
Publicado: (2021)

Efficacy of Drug-Coated Balloon Approaches for de novo Coronary Artery Diseases: A Bayesian Network Meta-Analysis
por: Zhong, Peng-Yu, et al.
Publicado: (2022)

Long-term outcomes of drug-coated balloon treatment of calcified coronary artery lesions: a multicenter, retrospective, propensity matching study
por: Shan, Yingguang, et al.
Publicado: (2023)

Drug-Coated Balloon vs. Stent for de novo Non-small Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Sun, Kaiwen, et al.
Publicado: (2021)

Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: A patient-level propensity-matched analysis
por: Pan, Liang, et al.
Publicado: (2022)

Percutaneous coronary intervention for a healed erosion with excimer laser coronary angioplasty and drug-coated balloon angioplasty: a case report
por: Sekimoto, Teruo, et al.
Publicado: (2023)

Drug-coated balloon: an effective alternative to stent strategy in small-vessel coronary artery disease—a meta-analysis
por: Felbel, Dominik, et al.
Publicado: (2023)

Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in de novo coronary chronic total occlusion intervention: A multicenter observational study
por: Wang, Xi, et al.
Publicado: (2023)

Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon
por: Zhang, Yuxuan, et al.
Publicado: (2021)

Efficacy and safety of drug-coated balloon combined with cutting balloon for side branch of true coronary bifurcation lesions: Study protocol for a multicenter, prospective, randomized controlled trial
por: Wu, Haoyu, et al.
Publicado: (2022)

Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial
por: Gao, Xiao-Fei, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Coronary artery aneurysm formation after paclitaxel-coated balloon-only intervention for de novo coronary chronic total occlusion
por: Jun, Eun Jung, et al.
Publicado: (2023)

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions
por: Ni, Leng, et al.
Publicado: (2022)

Feasibility and Safety of Drug-Coated Balloon-Only Angioplasty for De Novo Ostial Lesions of the Left Anterior Descending Artery: Two-Center Retrospective Study
por: Li, Chuang, et al.
Publicado: (2022)

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials
por: Cai, Jin-Zan, et al.
Publicado: (2018)

Case Report: Combination of Pressure Guidewire and Optical Coherence Tomography-Guided Drug-Coated Balloon Revascularization for Renal Artery Fibromuscular Dysplasia
por: Li, Yuxi, et al.
Publicado: (2022)

Clinical Outcomes of Drug-Coated Balloon Treatment After Successful Revascularization of de novo Chronic Total Occlusions
por: Jun, Eun Jung, et al.
Publicado: (2022)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Yong, et al.
Publicado: (2021)

A Case of Aneurysm Occurring at the Dissection Site after Intervention with Drug-Coated Balloon
por: Yuan, Song Lin, et al.
Publicado: (2021)

Modification of Cardiovascular Drugs in Advanced Heart Failure: A Narrative Review
por: Martínez-Sellés, Manuel, et al.
Publicado: (2022)

Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
por: Tervo, Jerry, et al.
Publicado: (2022)

Vascular Remodeling After Drug-Coated Balloon Treatment: Insight From Optical Coherence Tomography
por: Shin, Eun-Seok, et al.
Publicado: (2023)

Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one—a systematic review and meta-analysis
por: Kulyassa, Péter, et al.
Publicado: (2023)

Case Report: A balloon-based technique to remove a pearl-like embolus out of the coronary artery
por: Wu, Kaimin, et al.
Publicado: (2023)

Paclitaxel Particle Distribution 3 Months After Drug-Coated Balloon Treatment　― Zemporshe(®) Angioscopy Assessment ―
por: Ihara, Madoka, et al.
Publicado: (2020)

Culprit vessel revascularization first with primary use of a dedicated transradial guiding catheter to reduce door to balloon time in primary percutaneous coronary intervention
por: Guo, Jincheng, et al.
Publicado: (2022)

An analysis of published cases of cutting balloon use in spontaneous coronary artery dissection
por: Maričić, Bojan, et al.
Publicado: (2023)

Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion
por: Wang, Yong, et al.
Publicado: (2023)

Initial Experience in Transvenous Implantation of a Left Ventricular Lead With a Novel Venogram Balloon Catheter
por: Duan, Jiangbo, et al.
Publicado: (2022)

Distribution of Paclitaxel Particles on the Vascular Wall After Drug-Coated Balloon Treatment　― Electronic High-Resolution Angioscopy Assessment ―
por: Ihara, Madoka, et al.
Publicado: (2019)

Twelve-Month Results From the First-in-China Prospective, Multi-Center, Randomized, Controlled Study of the FREEWAY Paclitaxel-Coated Balloon for Femoropopliteal Treatment
por: Zhang, Bihui, et al.
Publicado: (2021)

In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023)

Self-expanding vs. balloon-expandable transcatheter heart valves in small aortic annuli
por: Kornyeva, Anastasiya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o1hr0oa0okjf03hjs75rgfmh3q